Delivery Order SPE2DB24D2205-SPE2DB25FEBSP
- Not listed
- The Defense Logistics Agency awarded a $43,711.26 firm fixed price delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL pen injectors (2 mL), with an ultimate completion date of October 21, 2025. This non-set-aside delivery order represents a competitively awarded pharmaceutical supply transaction supporting federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical...
- The Defense Logistics Agency awarded a $15,373.99 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injectors with an ultimate completion date of August 19, 2025. This non-set-aside contract represents a single delivery order fulfilling pharmaceutical procurement requirements for federal medical supply needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The Defense Logistics Agency awarded a $77,429.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pen injectors with an ultimate completion date of August 5, 2025. This non-set-aside contract represents a single delivery order fulfilling federal pharmaceutical procurement needs through competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor...
- The Defense Logistics Agency awarded a $21,852.02 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pen injectors with an ultimate completion date of August 19, 2025. This non-set-aside, competitively awarded contract represents a single delivery order fulfilling federal pharmaceutical procurement requirements. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a $147,013.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injectors, with a completion date of September 17, 2025. This non-set-aside contract represents a competitive award to the major pharmaceutical distributor, which maintains its corporate office in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $6,046.09 firm fixed-price delivery order to AmerisourceBergen Drug Corp on May 6, 2025, for the supply of Dupixent 300 mg/2 mL pen injectors. This is a non-set-aside competitive award with a completion date of May 7, 2025, with performance at the contractor's Conshohocken, Pennsylvania location. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp supplies a comprehensive range of...
- The Defense Logistics Agency awarded a delivery order valued at $8,347.93 to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pen injectors, with an ultimate completion date of October 20, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a single delivery order fulfillment for this pharmaceutical product. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor...
- The Defense Logistics Agency awarded a $73,368.18 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pen injectors, with an ultimate completion date of September 10, 2025. This non-competitive delivery order was issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion pharmaceutical prime vendor agreement running through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a $26,698.22 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pen injectors on June 4, 2025, with completion scheduled for June 5, 2025. This non-competitive, competitively awarded contract represents a small pharmaceutical procurement supporting federal medical supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- The Defense Logistics Agency awarded a $18,925.49 firm fixed price delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL pen injectors, with an ultimate completion date of July 15, 2025. This non-set-aside competitive award was issued on July 14, 2025, with performance to be executed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, was selected to supply...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEBSPDelivery Order
The Defense Logistics Agency awarded a $50,489.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL pen injectors with an ultimate completion date of May 1, 2025. This non-set-aside, competitively awarded contract represents a single delivery order fulfilling pharmaceutical supply requirements for federal medical procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for military and veteran healthcare systems through the DLA's medical supply chain. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of medications and medical supplies to support military healthcare programs worldwide, including support to the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's continued selection for such orders demonstrates its capability to meet federal procurement requirements through open competition and its role as a key vendor within the DLA's pharmaceutical procurement strategy.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $50.5k | 4/30/25 |